Order results by:
| Issue | Title | |
| Vol 16, No 2 (2020) | Mediterranean Diet: Origin History, Main Components, Evidence of Benefits and Feasibility to Adapt to the Russian Reality | Abstract similar documents |
| D. U. Akasheva, O. M. Drapkina | ||
| "... An unhealthy diet takes the lead in the concept of cardiovascular risk factors. It contributes ..." | ||
| Vol 20, No 6 (2024) | Rational approaches to the treatment of patients with overweight and obesity: a cardiologist’s view | Abstract similar documents |
| S. V. Miklishanskaya, N. A. Mazur | ||
| "... on the available data, the Mediterranean diet, brisk walking, and metformin, despite a slower and more moderate ..." | ||
| Vol 16, No 6 (2020) | Healthy Diet: New Rations for Individual Use | Abstract similar documents |
| O. B. Shvabskaia, N. S. Karamnova, O. V. Izmailova | ||
| "... recommendations. These are such diets as the Mediterranean type of food, the Scandinavian diet, the Tibetan style ..." | ||
| Vol 12, No 6 (2016) | ROLE OF NON-DRUG THERAPIES OF METABOLIC SYNDROME: CHALLENGES AND PROSPECTS | Abstract similar documents |
| S. N. Strelkova, K. V. Ovsyannicov, N. I. Utkina | ||
| "... prevalence, but also in the formation of a high risk of developing cardiovascular disease and diabetes type 2 ..." | ||
| Vol 11, No 2 (2015) | LOW SODIUM DIET: PROS AND CONS | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| "... Currently, there is rather contradictory evidence on the effectiveness of a low sodium diet ..." | ||
| Vol 19, No 1 (2023) | Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities | Abstract similar documents |
| A. V. Gorbenko, Y. P. Skirdenko, K. A. Andreev, M. M. Fedorin, N. A. Nikolaev, M. A. Livzan | ||
| "... types. The link between the gut microbiota and cardiovascular disease (CVD) is being actively ..." | ||
| Vol 16, No 5 (2020) | Possible Approaches to Primary Prevention of Cardiovascular Diseases | Abstract similar documents |
| V. N. Larina, D. S. Mkrtychev, V. A. Kuznetsova, A. A. Tyazhelnikov | ||
| "... with the development of cardiovascular diseases (CVD), allowed the experts of the American Heart Association to develop ..." | ||
| Vol 18, No 6 (2022) | Healthy Eating in Population Models of Nutrition: Asian Diet Style Summary | Abstract similar documents |
| O. B. Shvabskaia, N. S. Karamnova, O. V. Izmailova, O. M. Drapkina | ||
| "... researchers rightly associate with the nature of nutrition existing in these territories. The Japanese diet ..." | ||
| Vol 19, No 5 (2023) | Daily breakfast: will skipping a morning meal become a new prognostic marker? | Abstract similar documents |
| O. B. Shvabskaia, N. S. Karamnova, O. M. Drapkina | ||
| "... diabetes, cardiovascular diseases and the risk of cardiovascular death are presented and analyzed ..." | ||
| Vol 18, No 4 (2022) | Uric Acid as a Risk Factor for Cardiovascular Diseases | Abstract similar documents |
| A. S. Safaryan, A. S. Lishuta, D. V. Nebieridze | ||
| "... Recently, hyperuricemia and its association with cardiovascular disease have been receiving more ..." | ||
| Vol 7, No 5 (2011) | DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. V. Perova, V. A. Metel'skaya, E. I. Sokolov, G. N. Shchukina, V. M. Fomina | ||
| "... fats on the development of cardiovascular diseases and acute complications due to atherothrombosis ..." | ||
| Vol 17, No 6 (2021) | Hyperuricemia: Features of the Diet | Abstract similar documents |
| O. B. Shvabskaia, O. V. Izmailova, N. S. Karamnova, O. M. Drapkina | ||
| "... The association of hyperuricemia (HU) with cardiovascular disease (CVD), diabetes, metabolic ..." | ||
| Vol 17, No 5 (2021) | A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases | Abstract PDF (Eng) similar documents |
| Yu. V. Bulaeva, E. A. Naumova, O. N. Semenova, T. V. Kanaeva, K. A. Popov, А. R. Tyapayeva | ||
| "... therapy in patients with high or very high risk of cardiovascular complications. Material and methods ..." | ||
| Vol 16, No 1 (2020) | The Role of Red Yeast Rice Based Preparations for Non-Pharmacological Correction of Dyslipidemia in Patients with Low and Moderate Cardiovascular Risk (Expert Opinion) | Abstract similar documents |
| M. V. Ezhov, A. Catapano, C. Escobar, V. V. Kukharchuk, M. I. Voevoda, O. M. Drapkina, S. A. Shalnova, A. V. Starodubova, V. S. Gurevich, I. I. Shaposhnik, O. O. Bolshakova, O. S. Oynotkinova, A. S. Alieva | ||
| "... The Russian Federation is among countries with high cardiovascular risk. Hypercholesterolemia ..." | ||
| Vol 14, No 4 (2018) | Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome | Abstract similar documents |
| O. M. Drapkina, O. E. Shirobokikh | ||
| "... The role of gut microbiota in the pathogenesis of cardiovascular diseases (CVD) and metabolic ..." | ||
| Vol 19, No 3 (2023) | Nutraceutical support in the prevention and treatment of cardiovascular diseases | Abstract similar documents |
| E. V. Gracheva, E. A. Starovoytova, E. S. Kulikov, N. A. Kirillova, S. V. Fedosenko, M. A. Balaganskaya, D. V. Kromka | ||
| "... Cardiovascular disease is the most common cause of death worldwide. In this regard ..." | ||
| Vol 16, No 6 (2020) | Population-based Cardiovascular Disease Prevention Measures Aimed at Reducing Salt Intake: Analysis of International Strategies and Prospects for Implementation in the Russian Federation | Abstract similar documents |
| Yu. A. Balanova, A. V. Kontsevaya, N. S. Karamnova, D. K. Mukaneeva, O. M. Drapkina | ||
| "... High salt intake is an important risk factor for cardiovascular diseases (CVD), closely related ..." | ||
| Vol 6, No 6 (2010) | NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION | Abstract similar documents |
| E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya | ||
| "... Background. Effects of statins on cardiovascular end points are well-known. To study the impact ..." | ||
| Vol 3, No 3 (2007) | STRESS: WHAT WE ACTUALLY KNOW ABOUT THIS RISK FACTOR? | Abstract similar documents |
| R. G. Oganov, G. V. Pogosova | ||
| "... Results of current studies devoted to relationship between stress and cardiovascular morbidity ..." | ||
| Vol 11, No 5 (2015) | Three-year dynamics and unsolved problems of lipid-lowering therapy | Abstract similar documents |
| V. A. Sergeeva | ||
| "... of patients at a high cardiovascular risk of atherosclerosis problems and the dynamics of these parameters ..." | ||
| Vol 20, No 2 (2024) | Remote active monitoring of patients after myocardial infarction: are there any advantages over standard outpatient monitoring? | Abstract similar documents |
| D. Yu. Sedykh, T. S. Alkhimova, V. V. Kashtalap, O. L. Barbarash | ||
| "... , frequency of emergency cardiovascular hospitalizations due to coronary insufficiency, actual adherence ..." | ||
| Vol 16, No 6 (2020) | Chronic Kidney Disease: Current State of the Problem | Abstract similar documents |
| M. M. Batiushin | ||
| "... in relation to cardiovascular and general mortality, and, in most cases, is asymptomatic, which means late ..." | ||
| Vol 6, No 4 (2010) | HYPOANDROGEN CONDITION AND CARDIOVASCULAR DISEASES: ACTUAL QUESTIONS OF COMORBIDITY IN CLINICAL PRACTICE | Abstract similar documents |
| G. G. Sharvadze, D. G. Kurbatov, E. A. Poddubskaya, M. N. Mamedov | ||
| "... The correlation of age-dependent reduction in sex hormones level and changes of cardiovascular ..." | ||
| Vol 9, No 1 (2013) | EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS | Abstract similar documents |
| E. V. Akhmedova, Z. A. Toguzova, M. N. Mamedov | ||
| "... growth rate of mortality. Glucose blood levels should be monitored to reduce the risk of cardiovascular ..." | ||
| Vol 4, No 1 (2008) | ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| Vol 4, No 1 (2008) | WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL | Abstract similar documents |
| M. N. Mamedov, M. B. Stroeva | ||
| "... Primary prevention of diabetes in persons with high cardiovascular risk is an actual problem ..." | ||
| Vol 1, No 1 (2005) | MENOPAUSE AND CARDIOVASCULAR RISK | Abstract similar documents |
| D. A. Anichkov, N. A. Shostak, A. D. Zhuravleva | ||
| "... A role of menopause as a cardiovascular risk factor is reviewed. Menopause influence ..." | ||
| Vol 18, No 1 (2022) | Cardiovascular Effects of Metformin | Abstract similar documents |
| B. T. Kurmanbekova, A. M. Noruizbaeva | ||
| "... , progression and mortality from cardiovascular diseases (CVD). The world communities are faced ..." | ||
| Vol 20, No 5 (2024) | Lipoprotein(a), atherosclerosis and cardiovascular risk | Abstract similar documents |
| E. A. Polyakova, Iu. S. Khalimov, E. A. Bazhenova, T. M. Bakher | ||
| "... cardiovascular diseases. The atherogenicity of Lp(a) is 6 times higher than that of low-density lipoproteins ..." | ||
| Vol 4, No 4 (2008) | LOVASTATIN EFFECT ON VASCULAR REMODELING AND MYOCARDIAL SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. S. Kerimkulova, A. M. Noruzbaeva, O. S. Lunegova, B. Z. Imanov, M. A. Pavlenko, A. E. Mirrahimov, I. JU. Gottfried, E. M. Mirrahimov | ||
| "... to hypolipidemic diet and standard therapy. Patients of the 2nd group (n=39) were treated with diet and standard ..." | ||
| Vol 10, No 1 (2014) | MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) | Abstract PDF (Eng) similar documents |
| A. M. Kalinina | ||
| "... Aim. To evaluate in a prospective 10-year follow-up study cardiovascular mortality rate ..." | ||
| Vol 16, No 4 (2020) | Epicardial Adipose Tissue as a New Target of Therapeutic Interventions | Abstract similar documents |
| M. A. Druzhilov, T. Y. Kuznetsova | ||
| "... be considered as a potentially modifiable factor of cardiovascular risk, the various therapeutic interventions ..." | ||
| Vol 16, No 4 (2020) | Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues | Abstract similar documents |
| M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova | ||
| "... in a significant proportion of patients with atherosclerotic cardiovascular diseases (ACVD) is impossible ..." | ||
| Vol 5, No 3 (2009) | RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov | ||
| "... to provide high level of compliance in patients with cardiovascular diseases. ..." | ||
| Vol 5, No 4 (2009) | PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| "... The definition of primary prevention of cardiovascular diseases is presented. Statins preventive ..." | ||
| Vol 5, No 6 (2009) | EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) | Abstract similar documents |
| I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko | ||
| "... with different cardiovascular risk (according to arterial hypertension (HT) risk stratification) in real clinical ..." | ||
| Vol 6, No 1 (2010) | THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... Data of the evidence based medicine about bisoprolol treatment of patients with cardiovascular ..." | ||
| Vol 6, No 5 (2010) | LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? | Abstract similar documents |
| I. V. Zhirov | ||
| "... with cardiovascular diseases are presented. The main practical ways to reduce the possible gastrointestinal ..." | ||
| Vol 7, No 6 (2011) | DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE | Abstract similar documents |
| D. Yu. Platonov, T. A. Kostjuk, A. I. Brandt, O. V. Tsygankova | ||
| "... logistic regression. Results. Awareness of the cardiovascular diseases (CVD) and its prevention (odds ratio ..." | ||
| Vol 9, No 3 (2013) | STATINS AND RISK OF INFECTIOUS DISEASES | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| Vol 9, No 4 (2013) | STATINS IN PREVENTION OF ISCHEMIC STROKE | Abstract similar documents |
| A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk | ||
| Vol 9, No 4 (2013) | NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY | Abstract similar documents |
| A. V. Rudenko, B. A. Rudenko | ||
| "... cardiovascular events incidence in patients with atherosclerosis, even if they have no arterial hypertension ..." | ||
| Vol 10, No 5 (2014) | STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE | Abstract similar documents |
| V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
| "... modification of cardiovascular complications in the perioperative period. Particular attention has recently ..." | ||
| Vol 1, No 3 (2005) | RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS | Abstract similar documents |
| D. A. Anichkov, N. A. Shostak | ||
| "... The cardiovascular risk factors in patients with rheumatoid arthritis (RA) are reviewed ..." | ||
| Vol 11, No 6 (2015) | Alcohol consumption in patients with cardiovascular diseases (results of the survey of cardiac patients in outpatient practice) | Abstract similar documents |
| O. D. Ostroumova, I. E. Nikolaeva, S. Ya. Eregin, I. V. Pokrovskaya, K. A. Ishchenko | ||
| "... Aim. To study the frequency and characteristics of alcohol use in outpatients with cardiovascular ..." | ||
| Vol 5, No 1 (2009) | SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova | ||
| "... – arterial hypertension (HT) and hypercholesterolemia (HH) in patients with high risk of cardiovascular ..." | ||
| Vol 4, No 4 (2008) | BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST | Abstract similar documents |
| L. N. Malaj | ||
| "... Usage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed ..." | ||
| Vol 17, No 4 (2021) | Obstructive sleep apnea and cardiovascular comorbidity: common pathophysiological mechanisms to cardiovascular disease | Abstract similar documents |
| M. V. Agaltsov, O. M. Drapkina | ||
| "... Obstructive sleep apnea (OSA) is associated with many cardiovascular and metabolic diseases. Sleep ..." | ||
| Vol 12, No 1 (2016) | Effect of magnesium on the cardiovascular system in women | Abstract PDF (Eng) similar documents |
| E. A. Ulubieva, A. G. Avtandilov | ||
| "... Recent scientific data on the influence of magnesium on the cardiovascular and reproductive system ..." | ||
| Vol 6, No 4 (2010) | EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK | Abstract similar documents |
| N. V. Perova, E. I. Sokolov, G. N. Shchukina, V. A. Metelskaya | ||
| Vol 8, No 3 (2012) | MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... in different cardiovascular diseases are obtained. Physiological significance of magnesium is determined by its ..." | ||
| Vol 17, No 1 (2021) | Basic Aspects of Seasonal Cardiovascular Mortality | Abstract similar documents |
| G. F. Andreeva, V. M. Gorbunov | ||
| "... The review demonstrates the main aspects of seasonal cardiovascular mortality. Climatic factors ..." | ||
| Vol 14, No 2 (2018) | DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT | Abstract similar documents |
| N. В. Perepech, A. V. Tregubov | ||
| "... for primary and secondary prevention of cardiovascular diseases. 276 questionnaires filled out by 185 ..." | ||
| Vol 20, No 5 (2024) | Impact of non-high-density lipoprotein cholesterol in mortality and cardiovascular events among middle-aged Russian men: 40 years ago and now | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, A. E Imaeva, Yu. A Balanova, V. A Kutsenko, A. V Kapustina, V. A Metelskaya, N. A Imaeva, B. M Nazarov, O. E Ivlev, E. B Yarovaya, O. M Drapkina | ||
| "... in relation to cardiovascular events, all-cause and cause-specific mortality and among middle-aged Russian men ..." | ||
| Vol 17, No 4 (2021) | Inflammation and Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk? | Abstract similar documents |
| M. V. Zykov, O. L. Barbarash | ||
| "... in a special category of patients with extremely high cardiovascular risk, as well as in patients with recent ..." | ||
| Vol 18, No 5 (2022) | Assessment and Correction of the Cardiac Complications Risk in Non-cardiac Operations – What's New? | Abstract similar documents |
| A. N. Sumin | ||
| "... Cardiovascular complications after non-cardiac surgery are the leading cause of 30-day mortality ..." | ||
| Vol 19, No 2 (2023) | Antithrombotic Therapy in Patients with Paroxysmal Atrial Fibrillation after Catheter Treatment | Abstract similar documents |
| O. R. Eshmatov, M. S. Khlynin, R. E. Batalov, E. A. Archakov, I. V. Kisteneva | ||
| Vol 19, No 1 (2023) | Analysis of The Use of PCSK9 Inhibitors in Clinical Practice | Abstract similar documents |
| S. Yu. Volkova, L. A. Boyarskaya, P. Yu. Toropygin, I. A. Morozov, E. A. Boyarskaya | ||
| "... high cardiovascular risk, аccording to long observations in real clinical practice. Material ..." | ||
| Vol 12, No 3 (2016) | REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION" | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, M. M. Loukianov, N. P. Kutishenko | ||
| "... of various cardiovascular diseases (CVD) were among participants of the meeting. The importance of modern ..." | ||
| Vol 12, No 4 (2016) | Comparative Analysis of All-cause and Cardiovascular Mortality in Moscow and Irkutsk | Abstract PDF (Eng) similar documents |
| F. I. Belyalov, I. V. Samorodskaya, S. V. Pogodaeva | ||
| "... Aim. To study standardized all-cause mortality and cardiovascular mortality (or deaths due ..." | ||
| Vol 12, No 5 (2016) | The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies | Abstract similar documents |
| E. K. Butina, E. V. Bochkareva | ||
| "... Measures for the prevention of cardiovascular diseases (CVD) are more effective ..." | ||
| Vol 5, No 2 (2009) | DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, G. I. Furmenko, N. M. Akhmedzhanov | ||
| "... which treat and follow-up patients with cardiovascular diseases (CVD). Material and methods ..." | ||
| Vol 8, No 6 (2012) | THE RELATIONSHIP OF CARDIOVASCULAR RISK FACTORS AND ARTERIAL WALL STIFFNESS IN WOMEN WITH A HIGH ACTIVITY OF RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov | ||
| "... pulse wave) with cardiovascular risk factors in women with rheumatoid arthritis (RA). Material ..." | ||
| Vol 5, No 3 (2009) | CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE | Abstract similar documents |
| A. V. Kontsevaya, A. M. Kalinina, Yu. M. Pozdnyakov, S. V. Belonosova, M. B. Khudyakov | ||
| "... Aim. To study clinical and economical rationales for cardiovascular risk evaluation at workplace ..." | ||
| Vol 5, No 3 (2009) | ARTERIAL HYPERTENSION IN PATIENTS WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| N. M. Nikitina, A. P. Rebrov | ||
| Vol 5, No 4 (2009) | COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS | Abstract PDF (Eng) similar documents |
| N. A. Karoli, A. P. Rebrov | ||
| "... Aim. To study prevalence and features of cardiovascular diseases (arterial hypertension, ischemic ..." | ||
| Vol 13, No 1 (2017) | THE LINK BETWEEN VITAMIN В12 DEFICIENCY, RISK OF CARDIOVASCULAR DISEASES AND AGING PROCESS | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel | ||
| "... of the cardiovascular system. Its connections to the increased incidence of myocardial infarction, stroke ..." | ||
| Vol 13, No 3 (2017) | ARTERIAL STIFFNESS AND CARDIOVASCULAR RISK FACTORS IN YOUNG MEN (41-44 YEARS) | Abstract PDF (Eng) similar documents |
| O. Yu. Isaykina, V. B. Rozanov, E. Yu. Zvolinskaya, H. S. Pugoeva, A. A. Alexandrov | ||
| "... Aim. To study the relationship of individual cardiovascular risk factors with arterial stiffness ..." | ||
| Vol 13, No 6 (2017) | SMOKING AS A RISK FACTOR OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 1. Smoking Prevalence and Impact on Prognosis | Abstract similar documents |
| O. D. Ostroumova, A. A. Izvekov, N. Yu. Voevodina | ||
| "... of acute cardiovascular events during smoking include the activation of inflammation, platelet aggregation ..." | ||
| Vol 14, No 1 (2018) | SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking | Abstract similar documents |
| O. D. Ostroumova, I. I. Kopchjonov, T. F. Guseva | ||
| "... reduces the risk of developing stable and unstable angina, acute myocardial infarction, cardiovascular ..." | ||
| Vol 7, No 4 (2011) | METHODS OF ASSISTANCE FOR SMOKING CESSATION IN INTERNATIONAL CLINICAL RECOMMENDATIONS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE | Abstract similar documents |
| M. S. Berezhnova | ||
| "... of cardiovascular disease. There are a lot of approaches to drop smoking including innovative pharmacotherapy ..." | ||
| Vol 6, No 6 (2010) | THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina | ||
| "... concerning the evidence base for effects of various beta-blockers on the outcomes of cardiovascular diseases ..." | ||
| Vol 6, No 5 (2010) | EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY | Abstract similar documents |
| O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva | ||
| "... year worldwide, and cardiovascular complications happen in 500 000 - 900 000 patients. Aim ..." | ||
| Vol 6, No 5 (2010) | PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE | Abstract similar documents |
| M. N. Mamedov, G. G. Sharvadze, E. A. Poddubsky, A. K. Ausheva | ||
| "... of ED in the majority of men (about 80% of patients) is cardiovascular diseases (atherosclerosis ..." | ||
| Vol 11, No 1 (2015) | VASCULAR COMORBIDITY: GENERAL APPROACHES TO PREVENTION AND TREATMENT | Abstract PDF (Eng) similar documents |
| R. G. Oganov | ||
| "... The problem of vascular comorbidity in patients with cardiovascular diseases, its effect ..." | ||
| Vol 9, No 1 (2013) | CLINICAL AND COST EFFECTIVENESS OF PREVENTIVE COUNSELING OF YOUNG PATIENTS WITH ARTERIAL HYPERTENSION IN PRIMARY HEALTH CARE | Abstract similar documents |
| M. I. Shupina, O. Ju. Korennova, E. N. Loginova | ||
| "... . The total cardiovascular risk in patients of “Health school” and "Typical practice" groups after 12 months ..." | ||
| Vol 11, No 3 (2015) | OMEGA-3 FATTY ACIDS AND AGE-RELATED DISEASES: REALITIES AND PROSPECTS | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| "... acids are included into the treatment protocols for patients with cardiovascular diseases ..." | ||
| Vol 9, No 4 (2013) | USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? | Abstract similar documents |
| V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
| "... of risk modification of cardiovascular complications in the perioperative period. Therefore, special ..." | ||
| Vol 10, No 1 (2014) | ARTERIAL STIFFNESS AND CHRONIC KIDNEY DISEASE: CAUSES AND CONSEQUENCES | Abstract similar documents |
| J. D. Kobalava, Yu. V. Kotovskaya, S. V. Villevalde, A. E. Soloveva, I. M. Amirbegishvili | ||
| "... Chronic kidney disease (CKD) is associated with increased cardiovascular risk. CKD ..." | ||
| Vol 10, No 1 (2014) | MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT | Abstract similar documents |
| E. I. Trisvetova | ||
| "... Progression of cardiovascular disease is often caused by a deficiency of magnesium in the human ..." | ||
| Vol 10, No 4 (2014) | MODERN PRINCIPLES OF QUALITY ASSESSMENT OF CARDIOVASCULAR DISEASES TREATMENT | Abstract similar documents |
| A. Yu. Suvorov, S. Yu. Martsevich | ||
| "... The most common ways of assessment of cardiovascular diseases treatment abroad, approaches ..." | ||
| Vol 16, No 4 (2020) | Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice | Abstract similar documents |
| D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan | ||
| "... to cardiovascular risk require an optimization of their pharmacotherapy in clinical practice. Aim. To study ..." | ||
| Vol 11, No 5 (2015) | Perioperative assessment of troponin level in the non-cardiac interventions: is there such a need? | Abstract similar documents |
| A. N. Sumin | ||
| Vol 1, No 1 (2005) | ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES | Abstract similar documents |
| Y. A. Karpov | ||
| "... risk due to cardiovascular reasons. Favorable therapeutic effects of inhibiting RAS activity ..." | ||
| Vol 8, No 4 (2012) | UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina | ||
| "... cardiovascular diseases is one of the priorities of modern medicine. This therapy usually consists of several ..." | ||
| Vol 8, No 5 (2012) | ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? | Abstract similar documents |
| S. A. Boldueva, I. A. Leonova | ||
| "... and the main indications are discussed. ASA use for primary cardiovascular diseases prevention and its possible ..." | ||
| Vol 5, No 1 (2009) | CARDIOLOGICAL MANAGEMENT OF PREGNANT WOMEN IN THE UDMURT REPUBLIC | Abstract similar documents |
| I. R. Gaisin, R. M. Valeeva, L. V. Shilina, N. Yu. Chernisheva, N. I. Maksimov | ||
| "... Aim. To assess the efficacy of specialized management of pregnant women with cardiovascular ..." | ||
| Vol 5, No 1 (2009) | CLINICAL SIGNIFICANCE OF HEART RATE VARIABILITY INDEXES DERIVED FROM 5-MINUTE AND 24-HOUR ECG RECORDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. A. Anichkov, A. A. Platonova | ||
| "... association between HRV indexes and cardiovascular risk factors and RA-related clinical characteristics ..." | ||
| Vol 14, No 5 (2018) | Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study | Abstract similar documents |
| I. L. Polshakova, S. V. Povetkin | ||
| "... data, the type and duration of AF, cardiovascular diseases (CVD), concomitant noncardiac pathology ..." | ||
| Vol 4, No 4 (2008) | CARDIOVASCULAR EVENT RISK REDUCTION WITH MEDICINES: DATA OF EVIDENCE BASED MEDICINE AND RECOMMENDATIONS TO PRACTITIONERS | Abstract similar documents |
| S. Y. Martsevich | ||
| "... Cardiovascular event risk reduction with medicines is discussed in the article. The role ..." | ||
| Vol 4, No 5 (2008) | MOLECULAR MECHANISMS OF ACTION OF MAGNESIUM OROTATE ON CARDIOVASCULAR SYSTEM | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova | ||
| "... of orotic acid and magnesium orotate on cardiovascular system as well as therapeutic implementation ..." | ||
| Vol 15, No 4 (2019) | Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare | Abstract similar documents |
| O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel | ||
| "... of cardiovascular complications for primary prevention in a wide population are presented. The question of the ratio ..." | ||
| Vol 18, No 1 (2022) | Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data) | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Zagrebelnyy, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. S. Nekoshnova, I. V. Budaeva, S. V. Blagodatskikh, B. B. Aslanova | ||
| "... cardiovascular (CV) risk in real clinical practice. Material and methods. The general information of the study ..." | ||
| Vol 4, No 5 (2008) | COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS | Abstract similar documents |
| S. N. Tolpygina, S. Y. Martsevich | ||
| "... ,0 mmol/l and high cardiovascular risk were involved into the study. During 5 weeks before study including ..." | ||
| Vol 17, No 4 (2021) | Novel Biomarkers of Endothelial Dysfunction in Cardiovascular Diseases | Abstract similar documents |
| Z. M. Abdurakhmanov, B. Y. Umarov, M. M. Abdurakhmanov | ||
| "... and progression of cardiovascular diseases, stratification of their risks, since endothelial dysfunction (ED ..." | ||
| Vol 6, No 3 (2010) | BLUMENTHAL SCREENING FOR CARDIOVASCULAR RISK IN ASYMPTOMATIC PATIENTS | Abstract similar documents |
| J. S. Berger, C. O. Jordan, D. Lloyd-Jones, R.S. Blumenthal | ||
| "... Blumenthal screening for cardiovascular risk in asymptomatic patients. ..." | ||
| Vol 9, No 4 (2013) | VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... The problem of varenicline use in patients with cardiovascular diseases is discussed. Results ..." | ||
| Vol 16, No 1 (2020) | Obesity and Mechanisms of its Negative Impact on the Cardiovascular System | Abstract similar documents |
| S. V. Miklishanskaya, L. V. Solomasova, M. A. Mazur | ||
| "... , which create prerequisites for the development of cardiovascular diseases, as well as the existing ..." | ||
| Vol 1, No 3 (2005) | EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE | Abstract similar documents |
| G. De Backer, E. Ambrosioni, K. Borch-Johnsen, C. Brotons, R. Cifkova, J. Dallongeville, S. Ebrahim, O. Faergeman, I. Graham, G. Mancia, V. Manger Cats, K. Orth-Gomer, J. Perk, K. Pyorala, J. Rodicio, S. Sans, V. Sansoy, U. Sechtem, S. Silber, T. Thomsen, D. Wood | ||
| "... European guidelines on cardiovascular disease prevention in clinical practice. ..." | ||
| Vol 3, No 4 (2007) | GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES | Abstract similar documents |
| L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, K. Malmberg, S. Priori, J. Ostergren, J. Tuomilehto, I. Thrainsdottir | ||
| "... The Task Force on Diabetes and Cardiovascular diseases of the European Society of Cardiology ..." | ||
| 1 - 100 of 673 Items | 1 2 3 4 5 6 7 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
